RxDoctor Payments Data

Perrin Clark, MD

Otolaryngology/Facial Plastic Surgery · Ormond Beach, FLNPI 1194796128

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (57.1%), food and beverage and education — rather than concentrated in one kind of arrangement. Intersect ENT, Inc. accounts for 72.4% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $3,514 and has fallen 98.6% since, to $50 in 2025.

$4,152in general payments, 2019–2025

Across 38 payments — averaging $109.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intersect ENT, Inc.$3K
  • Regeneron Healthcare Solutions, Inc.$422
  • Stryker$296
  • Galderma Laboratories, L.p.$212
  • GSK$163
  • Hikma Pharmaceuticals USA$29
  • plus $24 from 1 others

What the payments were for

  • Travel & lodging$2,37157%
  • Food & beverage$1,69841%
  • Education$842%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,152 in reported general payments places this provider in the 70th percentile of 48 otolaryngology/facial plastic surgery providers in Florida.

See all otolaryngology/facial plastic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$425,372
Medicare patients
845
Services billed
3,602

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl388$11,793
Montelukast Sodium513$6,912
Fluticasone Propionate390$6,550
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth44$3,911
Doxycycline Hyclate143$2,441
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort49$2,278
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav126$1,934
Mupirocin233$1,876
Levocetirizine Dihydrochloride102$1,804
Ipratropium Bromide59$1,627
Pilocarpine Hcl26$689
Famotidine48$657
Clindamycin Hcl47$610
Omeprazole34$514
Hydrocortisone100$512

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Ormond Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →